Study identifier:NIS-GAT-NEX-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
LIFE NIS, GERD-Patients - Evaluation of Burden of Disease determined by GERD impact scale (GIS)
GERD
-
No
-
All
900
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|